Evidence is provided here that OMWW inhibits proliferation of cisplatin and gemcitabine resistant cells in a panel of bladder cancer cell lines by acting on the Cyclin-CDK-axis and the Akt-mTOR signaling cascade. Here, AKT1 is linked to urinary bladder cancer.